Assessing Change in Core Autism Symptoms: Challenges for Pharmacological Studies

Aman MG , Novotny S , Samango-Sprouse C , Lecavalie L , Leonard E , Gadow KD , King BH , Pearson DA , Gernsbacher MA , Chez M : Outcome measures for clinical drug trials in autism. CNS Spectrums, 9:36–48, 2004.

Arnold LE , Aman MG , Hollway J , Hurt E , Bates B , Li X , Farmer C , Anand R , Thompson S , Ramadan Y , Williams C : Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. J Child Adolesc Psychopharmacol, 22:198–205, 2012.

Butter EM , Mulick JA : Assessing the core symptoms of autism spectrum disorders: The development of the Ohio Autism Clinical Impressions Scale. Poster presented at the New Clinical Drug Evaluation Unit Conference, Boca Raton, FL, June, 2006.

Constantino JN , Davis SA , Todd RD , Schindler MK , Gross MM , Brophy SL , Metzger LM , Shoushtari CS , Splinter R , Reich W : Validation of a brief quantitative measure of autistic traits: Comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview-Revised. J Autism Developmental Dis, 33:427–433, 2003.

Guy W , editor:ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration, 1976.

Kanne SM , Mazurek MO , Sikora D , Bellando J , Branum-Martin L , Handen B , Katz K , Freedman B , Powell MP , Warren Z : The Autism Impact Measure (AIM): Initial development of a new tool for treatment outcome measurement. J Autism Developmental Dis, 44:168–179, 2014.

Reichow B : Overview of meta-analyses on early intensive behavioral intervention for young children with autism spectrum disorders. J Autism Developmental Dis, 42:512–520, 2012.

Sturmey P : Secretin is an ineffective treatment for pervasive developmental disabilities: A review of 15 double-blind randomized controlled trials. Res Developmental Disabilities, 26:87–97, 2005.

Virués-Ortega J : Applied behavior analytic intervention for autism in early childhood: Meta-analysis, meta-regression and dose-response meta-analysis of multiple outcomes. Clin Psychology Rev, 30:387–399, 2010.

Warren Z , Veenstra-VanderWeele J , Stone W , Bruzek JL , Nahmias AS , Foss-Feig JH , Jerome RN , Krishnaswami S , Sathe NA , Glasser AM , Surawicz T , McPheeters ML . Therapies for Children With Autism Spectrum Disorders. Comparative Effectiveness Review No. 26. (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2007-10065-I.) AHRQ Publication No. 11-EHC029-EF. Rockville, MD: Agency for Healthcare Research and Quality. April 2011. Available at: www.effectivehealthcare.ahrq.gov/reports/final.cfm.

Weitlauf AS , McPheeters ML , Peters B , Sathe N , Travis R , Aiello R , Williamson E , Veenstra-VanderWeele J , Krishnaswami S , Jerome R , Warren Z . Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update. Comparative Effectiveness Review No. 137. (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2012-00009-I.) AHRQ Publication No. 14-EHC036-EF. Rockville, MD: Agency for Healthcare Research and Quality; August 2014. www.effectivehealthcare.ahrq.gov/reports/final.cfm.